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Abstract 
Background 
Little is known about the prevalence of depression in people with diabetes in Bangladesh. 
This study examined the prevalence and factors associated with depression in out-patients 
with Type 2 diabetes in Bangladesh. 
Methods 
In this cross-sectional study a random sample of 483 diabetes out-patients from three diabetes 
clinics in Bangladesh was invited to participate. Of them 417 patients took part. Depressive 
symptoms were measured using previously developed and culturally standardized Bengali 
and Sylheti versions of the World HealthOrganization-5 Well Being Index (WHO-5) and the 
Patient Health Questionairre-9 (PHQ-9) with predefined cut-off scores. Data was collected 
using two different modes; e.g. standard assisted collection and audio questionnaire methods. 
Associations between depression and patient characteristics were explored using regression 
analysis. 
Results 
The prevalence depressive symptoms was 34% (PHQ-9 score ≥ 5) and 36% (WHO-5 
score < 52) with audio questionnaire delivery method. The prevalence rates were similar 
regardless of the type (PHQ-9 vs. WHO-5) and language (Sylheti vs. Bengali) of the 
questionnaires, and methods of delivery (standard assisted vs. audio methods). The 
significant predictors of depressive symptoms using either the PHQ-9 or WHO-5 
questionnaires were; age, income, gender, treatment intensity, and co-morbid cardiovascular 
disease. Further, depression was strongly associated with poor glycaemic control and number 
of co-morbid conditions. 
Conclusions 
This study demonstrated that depression prevalence is common in out-patients with type 2 
diabetes in Bangladesh. In a setting where recognition, screening and treatment levels remain 
low, health care providers need to focus their efforts on diagnosing, referring and effectively 
treating this important disease in order to improve service delivery. 
Keywords 
Diabetes, Depression, Prevalence, Risk factors, Bangladesh 
Background 
Evidence suggests that the prevalance of depression is elevated in those with chronic illnesses 
such as diabetes [1,2]. Current epidemiological evidence suggests that at least one third of 
people with diabetes suffer from clinically relevant depressive disorders [3-5]. However, in 
spite of the huge impact of co-morbid depression and diabetes on the individual and its 
importance as a public health problem, little is known about the existence of psychological 
problems in people with diabetes in Bangladesh or the Bangladeshi origin immigrant 
population in the west [6]; a population group who have a markedly increased risk of 
developing Type 2 diabetes mellitus (T2DM) [6-8]. Although there is a scant literature 
describing the prevalence of depression in Bangladesh, there is an assumption that the burden 
of mental disorders on the Bangladeshi population is high [9]. Limited data from South Asian 
settings have reported two to five-fold increases in the prevalence rates of depression in 
people with diabetes compared to people without diabetes [9-12]. One of the major 
challenges in assessing depression rates in South Asian countries is that no depression 
screening tools have been culturally standardized for these specific populations. Previous 
research has demonstrated the potential of a range of different modes of data collection in 
these ethnic groups (where illiteracy rates are high), including audio versions of 
questionnaires, as well as assisted completion, depending on the type of questionnaire to be 
completed [13]. Our recent research in the UK has developed culturally specific methods for 
administering and collecting reliable data on psychological morbidity in South Asian people 
with T2DM [14]. The present study set out to screen for the prevalence of and factors 
associated with the risk of depression in a random sample of out-patients with T2DM living 
in Bangladesh where literacy problems in data collection also arise, using recently developed 
and culturally standardized Bengali and Sylheti audio versions of the Patient Health 
Questionnaire-9 (PHQ-9) and the World Health Organization-5 Well-being Questionnaire 
(WHO-5). 
Methods 
Study sites 
The study was conducted between November 2010 and February 2011. We purposefully 
selected three sites for data collection, two in urban Dhaka and the other in suburban Sylhet. 
The three specific sites of data collection were i) the Bangladesh Institute of Research and 
Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) Hospital at 
Dhaka, ii) National Health Care Network facility operated by the Diabetic Association of 
Bangladesh in Dhaka, and iii) the Diabetic Association of Bangladesh Hospital in Sylhet. 
Subjects 
Individuals who had been diagnosed with T2DM for at least one year, spoke either Bengali or 
Sylheti and were attending the outpatient department of our selected sites for consultation 
were approached by the research team and invited to participate in the study. Further 
inclusion criteria were: (i) age 18–65 years, (ii) capable of independent communication, and 
(iii) capable of giving informed verbal consent to this study. Individuals who were currently 
being treated for depression or other psychological problems (e.g. anxiety or personality 
disorders) as ascertained at recruitment were excluded. In all settings, consecutive attendees 
in the diabetes outpatient department were randomly approached. Medical officers or resident 
physicians assisted with recruitment by allowing the researcher to sit in on consultations, 
during which time the study could be explained, and the patient invited to participate. Figure 
1 illustrates the flow of participants through the research study. During this study period, 483 
patients attending the three outpatient clinics were approached and invited for initial 
screening, of them 417 fulfilled inclusion criteria, provided informed consent and took part in 
the study. 
Figure 1 Flow participants through research study 
Instruments and measurement 
Previously developed and evaluated Bengali and Sylheti versions of the PHQ-9 and the 
WHO-5 were used. Our recent research in the UK has developed culturally specific methods 
for administering and collecting reliable and valid data on psychological morbidity in South 
Asian people with T2DM (specifically Mirpuri and Sylheti speakers) and established the 
cultural equivalency and face validity of two widely used depression screeners [14]. In this 
latter qualitative study, individuals with T2DM from two minority ethnic populations living 
in Birmingham, whose main language was only spoken and did not have an agreed written 
form, participated in a series of focus groups during which both the content and form of 
delivery of these screening tools designed to measure psychological wellbeing in people with 
diabetes were evaluated and culturally sensitive written and spoken translations were adopted 
[14]. 
The PHQ-9 consists of nine items on a 4-point likert-type scale. It has been shown to have 
good sensitivity and specificity with regard to identifying cases of depression as well as being 
sensitive to change over time [15-17]. Standard cut-off scores were used with the PHQ-9 to 
classify minimal (0–4), mild (5–9), and moderate to severe (≥10) symptoms of depression. 
The PHQ-9 can be used as a screening tool, with recommended cut-off scores of 10 or greater 
being found to have 88% sensitivity and 88% specificity for a diagnosis of major depression. 
The WHO-5 is a well-validated measure of positive well-being, widely used in a range of 
settings and has been shown to have good sensitivity to depressive symptoms or depressive 
affect [18-20]. Unlike most other scales, it is a positive mood scale, measuring the absence 
rather than the presence of negative mood during the past two weeks. The degree to which 
these feelings were present in the last 2 weeks is scored on a six-point Likert scale ranging 
from 0 (not present) to 5 (constantly present). The raw scores are transformed to a score from 
0 (worst thinkable well-being) to 100 (best thinkable well-being). A score < 52 suggests poor 
emotional well-being and is a sign for further testing. A score ≤ 28 is indicative of depression 
[18,19]. 
Prior to this study, written and audio versions of both questionnaires were developed in 
Bengali and Sylheti and evaluated through consultation with a group of Sylheti and Bengali 
speaking individuals with T2DM attending a diabetes outpatient department in Birmingham, 
UK [14]. The process of the development of audio version of these questionnaires has been 
reported elsewhere [14]. 
Procedure and evaluation 
A research team of 5 members was involved in this study. One of the investigators (TR) and 
four other trained research assistants (2 male and 2 female; fluent in Bengali/Sylheti) 
collected the data. A demographic form used in the previous study [14] was modified for use 
in Bangladesh to assess eligibility. During the selection process in the doctor’s consultation 
room those who agreed to take part were invited to move to a separate room (education 
room/counselling room) in the hospital to try out the methods. Female participants were 
mostly approached and interviewed by female research team members. However, if any male 
member interviewed them, they were accompanied by either a female member of hospital 
staff or the person attending the hospital with them. The aims of the study were explained to 
participants by the researcher and informed consent obtained using pre-validated audio 
methods [13,14]. Demographic and health related information was collected from each 
participant. Questions about health related variables included: age of onset & duration of 
diabetes, body mass index (BMI), fasting blood sugar (FBS), glycosylated haemoglobin 
(HbA1c) level, medications types, insulin treatment duration, leisure-time physical activity 
and co-morbidities. The most recent clinical data (e.g. BMI, medication history, FBS, HbA1c 
level) were collected from the patients’ “personal medical diary” [a handbook with all up to 
date medical records, which every patient has to carry during follow-up consultation visits] or 
medical records. 
Each session with individual participants consisted of two phases - the first of which was to 
complete two questionnaires (the PHQ-9 and the WHO-5) using the following modes of data 
collection: 
1. Standard assisted collection (Bengali version), with questions read out by the researcher 
and answered by the participant with the researcher completing the questionnaire for them. 
2. Independent audio collection (either Bengali or Sylheti version), with the participant 
listening to an audio recording of questions in the appropriate language/dialect, and 
responding independently using the colour-coded scoring system. 
For the second phase of the study and following questionnaire completion, the participants 
were asked to take part in a brief interview with the researchers in order to discuss their 
experiences of completing the PHQ-9 and the WHO-5 and to complete an evaluation 
proforma for each method tested. The evaluation proforma, developed during a previous 
study [14], was used to assess participants’ opinions on the administration and completion of 
audio-assisted methods. The detail description about the proforma and evaluation process are 
published elsewhere before [14]. 
Ethical approval for the main phase of the study in the UK was obtained via the Birmingham 
Heartlands Local Research Ethics Committee (now re-configured as part of the Integrated 
Research Application System [www.myresearchproject.org.uk]. The modified protocol for 
undertaking the study in Bangladesh was reviewed by project team members prior to 
obtaining ethical approval to carry out the study, from the Bangladesh Medical Research 
Council (BMRC) and the ethical review committee of BIRDEM, Bangladesh. The 
investigations were carried out in accordance with the principles of the Declaration of 
Helsinki as revised in 2000. 
Data analysis 
All statistical analyses were conducted using Statistical Package for Social Science version 
17 (SPSS Inc., Chicago). Comparisons between groups of subjects were performed using the 
student’s t-test for continuous variables and the Chi- square test for dichotomous variables. 
The internal consistency of the PHQ-9 and WHO-5 was measured by Cronbach’s α 
coefficient. Multiple logistic regression was used to assess the adjusted effects of explanatory 
variables on outcomes. Two separate models were conducted for the PHO-9 and the WHO-5 
scores respectively. A forward stepwise method was used to identify the best models with 
variables to a significance level of 5%. Only statistically significant variables at the univariate 
level were entered into the models. 
Results 
Demographic and clinical characteristics of the sample 
Of the 483 who were invited to participate, 86% (n = 417) completed both questionnaires, of 
whom 49.4% (n = 206) were female. The mean age of the subjects was 53.2 years. Just under 
half (45%, n = 189) of the respondents were Sylheti speakers. As shown in Table 1, Sylheti 
speakers were mostly rural in origin and had lower levels of education compared with 
Bengali speakers. There was no other significant difference observed between Sylheti 
speakers and Bengali speakers in terms of demographic, metabolic and clinical 
characteristics. More than one third of the respondents (35%, n = 145) were on insulin 
treatment, with 31% (n = 130) reporting high blood pressure and 18% (n = 75) reporting a 
history of cardiovascular disease. One fifth (20%, n = 83) of study participants reported more 
than one other co-morbidity. 
Table 1 Participants according to demographic information and literacy skill 
Category Total Sample Sylheti speakers Bengali speakers 
Total approached for screening (n) 483 220 263 
Total recruited and taken part % (n) 86 (417/483) 45 (189/417) 55 (228/417) 
Hospital    
BIRDEM, Dhaka % (n) 40.3 (168/417) 21 (35/168) 79 (133/168 
NHN, Dhaka % (n) 20.6 (86/417) 14 (12/86) 86 (74/86) 
BADAS Hospital Sylhet % (n) 39 (163/417) 87 (142/163) 13 (21/163) 
Current Age (Mean + SD) 53.2 (7.6) 53.9 (8.2) 53 (6.9) 
% (n) Female 49.4 (206/417) 47 (89/189) 51 (117/228) 
Monthly income in Taka 
a
 9684 ± 6265 9376 ± 6096 9873 ± 6497 
% (n) on insulin treatment 35 (145/417) 40 (75/189) 31 (70/228) 
Duration of Insulin Treatment (in years) (Mean + SD) 10.3 (3.9) 10.9 (4.0) 9.8 (3.8) 
% (n) Illiterate (n) 42.3 (176/417) 50 (94/189) 36 (82/228) 
% (n) rural resident 55.4 (231/417) 79 (149/189) 16 (37/228) 
% (n) Sylheti speakers 45.3 (189/417) NA NA 
Bengali Language Skill    
% (n) Can’t speak, read or write 17 (70/417) 65.4 (67/189) 1 (03/228) 
% (n) Can speak only; can’t read or write 17 (72/417) 2 (04/189) 30 (68/228) 
% (n) Can read or write only; can’t speak 11 (45/417) 24 (45/189) - 
% (n) Can speak, read and write 55 (233/417) 38.6 (78/189) 70 (157/228) 
Treatment intensity    
% (n) Oral medication + diet 65 (272/417) 60 (114/189) 69 (158/228) 
% (n) Insulin 19.4 (81/417) 23 (44/189) 16 (37/228) 
% (n) Insulin + oral medication 15.3 (64/417) 16 (31/189) 15 (33/228) 
% reported leisure-time physical activity 81.3 (339/417 86 (162/189) 78 (177/228) 
Type of co-morbidity    
% (n) Cardiovascular Disease 
b
 18 (75/417) 18 (34/189) 18 (41/228) 
% (n) Hypertension (SBP >140/DBP > 90 mmHg) 31 (130/417) 37 (70/189) 26 (60/228) 
% (n) Others (Kidney/eye problem nephropathy) 4 (18/417) 6.3 (12/189) 3 (06/228) 
SBP [mmHg] (Mean ± SD) 124 (17) 127 (19) 121 (16) 
DBP [mmHg] (Mean ± SD) 78 (11) 79 (13) 76 (10) 
BMI (g/cm2) (Mean ± SD) 24.5 (4.2) 24.7 (4.6) 24.8 (4.5) 
% (n) BMI ≤30 g/cm2 68 (283/417) 69.5 (131/189) 71 (161/228) 
% (n) BMI > 30 g/cm2 32 (134/417) 30.5 (58/189) 29 (67/228) 
FBS level (mg/dl) (Mean ± SD) 154.7 (57.4) 158.6 (59.3) 152.4 (52.7) 
HbA1c level (mmol/mol)(Mean ± SD) 65 (−8) 67(−7) 65(−9) 
Age at Diagnosis (Mean ± SD) 40 (3.3) 40.3 (3.4) 39.7 (3.1) 
Duration of Medication [in years] (Mean + SD) 13.2 (6.7) 13.6 (7.3) 12.9 (6.3) 
Number of medication (Mean ± SD) 3.8 (1.9) 3.9 (1.9) 3.8 (1.8) 
Number of co-morbidity (Mean ± SD) 1.2 (0.5) 1.3 (0.5) 1.2 (0.5) 
a
One US$ = 84 Bangladeshi Taka 
b
cardiovascular disease, includes conditions such as coronary heart disease (angina and heart 
attack) and stroke 
SD standard deviation 
BIRDEM Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and 
Metabolic Disorders 
NHN National Health Care Network 
BADAS Diabetic Association of Bangladesh 
SBP systolic blood pressure 
DBP diastolic blood pressure 
BMI body mass index 
FBS fasting blood sugar 
HbA1c glycosylated haemoglobin 
Reliability and item analysis 
Cronbach’s α for the PHQ-9 scale was 0.89 and for the WHO-5 it was 0.93. The correlations 
between nine items of the PHQ-9 and total PHQ-9 scores ranged from 0.71 to 0.83, and all 
correlations were significant at the 0.01 level. Likewise, the correlations between the five 
items of the WHO-5 and total WHO-5 scores ranged from 0.73 to 0.89 (with all correlations 
significant at the 0.01 level) [data not shown in the Table]. 
Prevalence of depression 
Table 2 shows the mean scores and the proportion of elevated scores on the two measures of 
depression by method of completion, spoken language and gender of the respondents. The 
prevalence of depressive symptoms using the PHQ-9 (score ≥5) was 34% (n = 142) when 
using the audio questionnaire delivery method. When a cut-off value (PHQ-9 ≥10) indicative 
of moderate to severe depression was used, the prevalence was found to be 16.5% (n = 69). 
Using the commonly used criteria of the WHO-5 (score < 52, a sign for further testing), 36% 
of the respondents reported poor well-being when using the audio data collection method. 
When a lower WHO-5 score (≤ 28) was used, 17.5% of the patients had scores that were 
suggestive of clinical depression. The prevalence rates of depression were significantly 
higher in females with T2DM compared with males with T2DM for both screeners (Table 1). 
The prevalence of depressive symptoms as measured either by the PHQ-9 or the WHO-5 
were similar regardless of the language of the questionnaires (Sylheti vs. Bengali) or the 
method used (the standard assisted vs. independent audio) to complete the questionnaires. 
Table 2 Prevalence of depression (WHO-5 or PHQ-9) in Sylheti and Bengali speakers 
with type 2 diabetes mellitus 
Category Audio method 
b
(n = 417) 
Standard 
Assisted 
method 
c
(n = 417) 
Sylheti speakers 
(n = 189) 
Bengali 
speakers 
(n = 228) 
Female 
(n = 206) 
Male 
(n = 211) 
PHQ-9 score 
(Mean ± SD) 
4.1 ± 6.1 4.3 ± 6.2 4.2 ± 6.4 4.0 ± 5.9 5.1 ± 6.3 3.1 ± 5.8 
% (n) Depression 
(sore ≥5-27) 
34(142) 33 (137) 36.5 (69) 32 (73) 43 (89) 
a
 25 (53) 
% (n) PHQ-9 score 
10 or above 
16.5 (69) 15.5 (65) 18.5 (35) 14.9 (34) 21.8 (45) 
a
 11.4 (24) 
WHO-5 score 
(Mean ± SD) 
54 ± 26 52 ± 27 53 ± 27 56 ± 25 46 ± 23 63 ± 28 
% (n) WHO-5 < 52 
(poor well-being) 
d
 
36 (151) 38 (158) 38.6 (73) 34 (78) 46.6 (96) 
a
 26 (55) 
% (n) WHO-5 ≤ 28 
(depressive affect) 
17.5 (73) 16.8 (70) 19 (36) 16 (37) 22.8 (47) 
a
 12 (26) 
a
p < 0.01comparing female and male with Type 2 diabetes 
b
Audio method (either Bengali or Sylheti version), with the participant listening to an audio 
recording of questions in the appropriate language/dialect, and responding independently 
using the colour-coded scoring system 
c
Standard assisted method (Bengali version), with questions read out by the researcher and 
answered by the participant with the researcher completing the questionnaire for them 
d
using the alternative cut-off value WHO-5 < 50 resulted in the same percentages 
Factors associated with depression 
Table 3 illustrates the results of univariate analysis examining the associations between 
demographic and clinical factors and depression symptoms (using PHO-9 scores ≥10 and 
WHO-5 scores ≤ 28). The prevalence of symptoms of depression was more than three times 
higher in women compared with men for the PHQ-9 (Odds ratio[OR] 3.4; 95% confidence 
interval [CI] 2.2-5.4) and for the WHO-5 questionnaires; it was 2.7 times higher (OR 2.7; 
95% CI 2.0-3.9) in women compared with men. For both the PHQ-9 and the WHO-5, other 
demographic variables that found statistically significant were low income, older age, lower 
education level and urban residence. Among the metabolic and clinical variables, patients on 
insulin or combined insulin and oral treatment, those taking a higher number of medications, 
those with co-morbid heart disease or a higher number of co-morbidities, and higher BMI, 
FBS and HbA1c values were all found to be significantly associated with a greater risk for 
depression, for both questionnaires and both methods of questionnaire completion. 
Table 3 Univariable regression examining the associations between demographic and 
clinical factors and depression symptoms (PHO-9 score ≥10 and WHO-5 score ≤ 28) 
Variables PHQ-9 WHO-5 
 OR (95% CI) OR (95% CI) 
Current Age (r = lowest value, 41 years) 1.8 (1.3-2.2) 
b
 1.7 (1.0-2.5) 
b
 
Female (r = male) 3.4 (2.2-5.4) 
b
 2.7 (2.0-3.9) 
b
 
Schooling in year (r = 0) 0.7 (0.5-1.6) c 0.6 (0.4-1.5) c 
Monthly Income > 6000 Taka (r = ≤ 6000 Taka) a 0.4 (0.3-0.9)b 0.5 (0.3-1.1) b 
Urban resident (r = rural) 1.6 (1.0-2.8) 
c
 1.5 (0.9-4.2) 
c
 
Treatment Centre (r = BADAS Hospital Sylhet) 1.3 (0.7-3.8) 1.2 (0.6-3.5) 
Sylheti Speaker (r = Bengali speaker) 1.1 (0.6-2.4) 1.0 (0.5-3.1) 
Method of data collection (r = audio collection method) 1.0 (0.5-2.3) 1.1 (0.6-3.3) 
Treatment intensity   
Insulin (r = oral medication + diet) 1.4 (1.0-2.8) 
c
 1.5 (1.1-3.2) 
c
 
Insulin + oral medication (r = oral medication + diet) 1.7 (1.0-2.9) 
c
 1.8 (1.0-3.4) 
c
 
Duration of Medication (r = lowest value, 2 years) 1.1 (0.7-3.3) 1.2 (0.6-3.8) 
Number of medication (r = lowest number, 3 medicines) 1.5 (0.8-2.2) 
c
 1.4 (0.8-2.4) 
c
 
Co-morbidity   
Cardiovascular Disease (r = no co-morbidity) 1.8 (1.2-2.5) 
b
 2.1 (1.5-3.2) 
b
 
Hypertension (r = no co-morbidity) 1.2 (0.5-3.9) 1.1 (0.5-3.7) 
Kidney/eye problem/nephropathy (r = no co-morbidity) 1.0 (0.5-3.4) 1.0 (0.6-3.5) 
Number of co-morbidity (r = 0) 2.2 (1.4-3.5) b 2.4 (1.5-3.4) b 
BMI (r = lowest value, 21.3 g/cm2) 0.7 (0.4-1.1) 
c
 0.6 (0.3-1.2) 
c
 
FBS level (r = lowest value, 97.3 mg/dl) 1.8 (1.1-2.5) 
b
 1.6 (1.1-3.1) 
b
 
HbA1c level (r = lowest value, 40 mmol/mol) 2.1 (1.7-2.8) 
b
 2.4 (1.5-3.1) 
b
 
a
One US$ = -84 Bangladeshi Taka 
b
P value <0.01 
c
P value <0.05; r = reference category 
WHO-5 World Health Organization-5 Well Being Index 
PHQ-9 Patient Health Questionairre-9 
OR odds ratio 
CI confidence interval 
Table 4 presents the results of the multivariate logistic regression, identifying the significant 
independent predictors of depression symptoms (using PHO-9 score ≥10 and WHO-5 
score ≤ 28). For both models (PHQ-9 and WHO-5); female sex, lower income, older age, 
patients with combined insulin and oral therapy, co-morbid heart disease and a higher number 
of co-morbidities were all found to be independent predictors for depression. Poor glycaemic 
control (as indicated by high FBS and HbA1c values), was also revealed as a strong predictor 
for depression in both models (Table 4). In both multivariate models, number of medications 
and obesity (indicated by BMI > 30.0 kg ⁄m2) were not associated with depressive symptoms 
after controlling for other factors. 
Table 4 Multivariate logistic regression predicting depression symptoms (PHO-9 
score ≥ 10 and WHO-5 score ≤ 28) by demographic characteristics, metabolic risk 
factors and diabetes complications 
Variables PHQ-9 WHO-5 
 OR (95% CI) OR (95% CI) 
Current Age (r = lowest value, 41 years) 1.5 (1.0-1.8) 
c
 1.6 (1.1-2.0) 
c
 
Female (r = male) 2.8 (2.0-4.8) 
b
 2.3 (1.8-3.7) 
b
 
Schooling in year (r = 0) 0.9 (0.6-2.8) 0.8 (0.4-2.5) 
Monthly income > 6000 Taka (r = ≤ 6000 Taka) a 0.5 (0.3-1.0) b 0.6 (0.4-1.2) b 
Urban resident (r = rural) 1.3 (0.7-3.8) 1.2 (0.6-3.5) 
Treatment intensity   
Insulin (r = oral medication + diet) 1.2 (0.8-2.6) 1.2 (0.7-3.4) 
Insulin + oral medication (r = oral medication + diet) 1.6 (1.0-2.8) 
c
 1.5 (1.0-3.1) 
c
 
Number of medication (r = lowest number, 3 medicines) 1.1 (0.8-3.2) 1.2 (0.8-3.8) 
Co-morbidity   
Cardiovascular Disease (r = no co-morbidity) 1.6 (1.1-2.3) 
b
 1.8 (1.3-3.3) 
b
 
Hypertension (r = no co-morbidity) 1.1 (0.5-3.8) 1.1 (0.4-3.5) 
Kidney/eye problem/nephropathy (r = no co-morbidity) 1.0 (0.5-3.4) 1.0 (0.6-3.5) 
Number of co-morbidity (r = 0) 1.8 (1.2-3.3) 
b
 2.1 (1.3-3.7) 
b
 
BMI (r = lowest value, 21.3 g/cm2) 0.9 (0.3-1.9) 0.8 (0.2-2.1) 
FBS level (r = lowest value, 97.3 mg/dl) 1.6 (1.0-2.8) 
c
 1.5 (1.0-2.9) 
c
 
HbA1c level (r = lowest value, 40 mmol/mol) 2.0 (1.4-3.3) 
b
 2.1 (1.3-3.7) 
b
 
a
One US$ = 84 Bangladeshi Taka 
b
P value <0.01 
c
P value <0.05 
The prevalence of depression used as dependent variable in the logistic regression analysis 
was derived from the standard assisted data collection or the audio data collection 
Discussion 
This study examined the prevalence of and factors associated with depression in a random 
sample of out-patients with T2DM in Bangladesh. To our knowledge, this is the first study 
that has investigated the prevalence of depression using data collected through two different 
modes; i.e. standard assisted collection and audio questionnaire methods. We found similar 
prevalence rates of depressive symptoms regardless of which screening tool was used (PHQ-
9 vs. WHO-5), and regardless of the language of the questionnaires (Sylheti vs. Bengali) or 
the method used (the standard assisted vs. independent audio method). 
Our study provides evidence that depression is common in T2DM in Bangladeshi settings. 
More than one-third of individuals reported poor emotional well-being using the WHO-5 
questionnaire and similar prevalence rates of depressive symptoms in patients with T2DM 
when using the PHQ-9. When using a lower cut-off value for the WHO-5 (score ≤ 28) or a 
cut-off value for the PHQ-9 (score ≥10) indicative of moderate to severe depression, the 
prevalence rates of depression were very similar for both questionnaires. These prevalence 
rates are in the line with recent studies that have used PHQ-9 in the primary care settings 
[21,22]. This prevalence of poor wellbeing and depressive affect is also comparable to the 
results of one recent study in diabetic out-patients that reported poor wellbeing in 35–38% 
and depressive affect in 18–25% of patients with T2DM [19]. A handful of studies have 
reported a higher prevalence of depression in people with T2DM compared with those 
without diabetes or in the general population [23-25]. In a systematic review of cross-
sectional prevalence data, Ali et al. [2] also reported significantly higher rates of depression 
in those with T2DM compared to adults without. 
An earlier population-based study in Bangladesh has reported almost similar rates of 
depressive symptoms (29.7%) in a rural population with diabetes using the Montgomery-
Asberg Depression Rating Scale [9]. In that earlier study higher socio-economic status and a 
high BMI were found to be protective factors against depression. We also observed these 
links in our current study population in Bangladesh, however this association was no longer 
significant at the multivariate level when controlling for other demographic and clinical 
variables. 
The earlier study further reported that depression was associated with poverty and the authors 
assumed that as poverty is more prevalent in rural areas, the prevalence of depression may 
also be higher [9]. Our sample comprised a mix of urban and rural populations and although 
we found a similar link between poverty and depression, in fact the opposite association was 
observed in terms of participants’ area of residence. At the univariate level urban residents 
with T2DM were nearly twice as likely to be depressed as rural residents when measured 
using either the PHQ-9 or WHO-5 questionnaires. However, this association no longer 
persisted after controlling for other confounding factors. 
Consistent with the results of other published studies in Bangladesh and elsewhere [2,9,23], 
our results demonstrated a significantly higher prevalence of depression in women with 
T2DM compared with men with T2DM. After controlling for potential confounding factors, 
gender remained as the strongest risk factor for depressive symptoms, with nearly a threefold 
increase risk in females compared with males. 
Poor glycaemic control was also a strong predictor of depression in our sample for both 
multivariate models. This finding is in line with previous studies [23]. It is known that 
depression has a negative impact on quality of life and that depression worsens glycaemic 
control [5,26]. Numerous studies, overwhelmingly cross-sectional, support our findings and 
suggest that depression is associated with suboptimal glycaemic control, although in a 
systematic review the effect size was mild [5]. A recent prospective study demonstrated a 
clear prospective association between depression at baseline and persistently higher HbA1c 
levels over a 4 year period [27]. 
Our findings also suggest that the presence of one or more complications, in particular 
cardiovascular disease, was significantly associated with depression in patients with T2DM. 
This finding is in line with recent studies that show that the risk of depression is significantly 
associated with the number of diabetes-related complications [21,28]. Having multiple 
chronic diseases in addition to diabetes has a high impact on well-being, quality of life and 
functioning and thus may contribute to further development of depression [29]. It is 
suggested that patients with severe diabetes-related complications, especially late micro- and 
macro-vascular complications such as retinopathy, nephropathy, neuropathy or 
cardiovascular disease, are more likely to be referred to specialized clinics. If these patients 
are adequately treated, they are more satisfied with their care and overall functioning [28]. 
Our findings are relevant for clinicians and nurses who work in diabetes outpatient clinics in 
order to take timely decisions for appropriate referral. 
Evidence also suggest that complications and depression often coexist and the prevalence of 
depression is particularly increased in those with longer lasting T2DM, but not in 
undiagnosed T2DM or those with impaired glucose metabolism [30]. A number of studies 
highlighted that the incidence of depression is increased in T2DM [31,32] and that depression 
is a risk factor for T2DM [33]. However, It is important to increase our understanding of the 
temporal relationship between the development of secondary complications and the onset or 
recurrence of depression. Future studies should aim to address these issues. 
One of the major challenges in measuring depression in Bangladesh is that no depression 
screening tools have previously been culturally standardized for the population in 
Bangladesh. Our previous research in the UK has developed culturally specific methods for 
administering and collecting reliable and valid data on psychological morbidity in South 
Asian people with T2DM (including Bengali and Sylheti speakers) and has established the 
face validity and cultural equivalency of two widely used depression screeners (the PHQ-9 
and WHO-5) [14]. This research used those culturally standardized tools and demonstrated 
their utility as potential depression screeners in wider sample like current study population. 
A number of studies documented that depression symptomatology is influenced by social and 
cultural factors [14]. In contrast, this study gives us the impression that the prevalence rates 
and the risk factors for depression in Bangladesh are very similar to European countries and 
the US [19,22,23,26]. Thus, it provides a room for argument that even if the meaning of 
depression varies cross-culturally, its crude prevalence or association to risk factors may not 
be culture specific. 
The findings of this study have major implications for clinical practice in Bangladesh, where 
physicians’ recognition of mental disorder rates is low and improving recognition rates is a 
challenge because of the high patient loads and poor undergraduate training in these skills. 
Providing the patients with the results of blood sugar, cholesterol, blood pressure and 
medications plan through outpatient service is not enough itself to improve service delivery 
and bring about change [34]. We need to overcome therapeutic inertia and low diabetes 
health literacy [35]. There is increasing recognition that patients with diabetes and depression 
require adequate mental healthcare, however, evidence in favour of routine screening and 
monitoring is not conducive yet. A few studies have tested whether screening for depression 
or monitoring of psychological well-being has beneficial effects, but results of these studies 
are conflicting to come to any conclusion [36-39]. 
In the developed world (for example in the North America and UK), self management is 
available for all new cases of diabetes. Undoubtedly, the patients with co-morbid diabetes 
and depression in Bangladesh would benefit from this approach. In the Bangladeshi settings, 
the clinician who sees the patients with diabetes could take on the role of initial assessment 
for depression and coordinate referral to mental health clinic for therapy and onward referral 
and follow-up with the patients [40]. 
Strengths and limitations of the study 
The strengths of our study include a high response rate and the inclusive nature of our 
research as individuals could participate regardless of literacy level. Including patients from 
two different ethnic backgrounds in Bangladesh was a further strength. Rather than having to 
rely on self-report, we were able to use information from patients’ medical diaries to gather 
information about diabetes, glycaemic control and the presence of diabetes complications. 
Also, a reasonable sample size and ascertaining depression with culturally standardized 
questionnaires are strengths of this study. 
However, an important limitation of our study was that we did not use a psychiatric 
diagnostic interview such as the Composite International Diagnostic Interview (CIDI), which 
is considered as the gold standard for the diagnosis of depression. Although it is suggested 
that the PHQ-9 can be used as a diagnostic assessment in primary care settings, however, the 
gold standard is still a diagnostic interview and a PHQ-9 diagnosis is regarded as inferior to 
the diagnostic interview. 
In addition, no information was available on the sample’s use of antidepressants, pain scores 
or daily living activities. This could bias the results, as patients who take antidepressants may 
have a low PHQ-9 or WHO-5 scores. 
Conclusion 
In conclusion, this study demonstrated that depression is a common co-morbid health 
problem in T2DM out-patients in Bangladesh, with more than one-third of patients reporting 
elevated depression scores regardless of depression screeners and data collection methods 
used. Within this sample of out-patients with diabetes, we found that female gender, older 
age, low income, treatment with combine insulin and oral medications, poorly controlled 
T2DM, and those with coexisting complications of diabetes were independent risk factors for 
depression symptoms. 
This study provides rich data on the prevalence and determinants of depression in T2DM 
outpatients in Bangladesh. In a setting where recognition, screening and treatment levels 
remain low, health care providers need to focus their efforts on diagnosing, referring and 
effectively treating this important disease in order to deliver rights-based and client-centred 
services for people in real needs. 
Competing interests 
The authors declare that they have no competing interests. 
Authors’ contributions 
CEL conceptualized and designed the study. TR collected data, conducted statistical analyses 
and prepared the manuscript. All authors made significant contributions to the conception and 
design of the analyses, interpretation of the data, and drafting of the manuscript, and all 
authors approved the final manuscript. 
Acknowledgements 
We would like to thank the participants in the study, and other members of the data collection 
team. Financial support for the study was provided by the Diabetes UK and the Dialogue on 
Diabetes and Depression, UK. 
References 
1. Palinkas LA, Wingard DL, Barrett-Connor E: Chronic illness and depressive symptoms 
in the elderly: a population-based study. J Clin Epidemiol 1990, 43:1131–1141. 
2. Ali S, Stone M, Peters J, Davies M, Khunti K: The prevalence of co-morbid depression 
in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 
23:1165–1173. 
3. Barnard K, Skinner T, Peveler R: The prevalence of co-morbid depression in adults 
with type 1 diabetes: systematic literature review. Diabet Med 2006, 23:445–448. 
4. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of co-morbid 
depression in adults with diabetes. Diabetes Care 2001, 6:1069–1078. 
5. Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE: 
Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes 
Care 2000, 23:934–942. 
6. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025. Diabetes Care 
1998, 21:1414–1431. 
7. Khunti K, Kumar S, Brodie J: Executive summary, diabetes UK and South Asian health 
foundation recommendations on diabetes research priorities for British South Asians. 
London: Diabetes UK; 2009. 
8. Patel V, Pereira J, Coutinho L, Fernandes R, Fernandes J, Mann A: Poverty, 
psychological disorder and disability in primary care attenders in Goa, India. Br J 
Psychiatry 1998, 171:533–536. 
9. Asghar S, Hussain A, Ali S, Khan A, Magnusson A: Prevalence of depression and 
diabetes: a population-based study from rural Bangladesh. Diabet Med 2007, 24:872–
877. 
10. Zahid N, Asghar S, Claussen B, Hussain A: Depression and diabetes in a rural 
community in Pakistan. Diabetes Res Clin Pract 2008, 79:124–127. 
11. Muhammad Gadit AA, Mugford G: Prevalence of depression among households in 
three capital cities of Pakistan: need to revise the mental health policy. PLoS One 2007, 
2:e209. 
12. Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P: Prevalence & determinants of 
depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res 2010, 
132:195–200. 
13. Lloyd CE, Sturt J, Johnson MRD, Mughal S, Collins G, Barnett AH: Development of 
alternative modes of data collection in South Asians with type 2 diabetes. Diabet Med 
2008, 25(4):455–462. 
14. Lloyd CE, Roy T, Begum S, Mughal S, Barnett AH: Measuring psychological wellbeing 
in South Asians with diabetes; a qualitative investigation of the PHQ-9 and the WHO-5 
as potential screening tools for measuring symptoms of depression. Diabet Med 2012, 
29(1):140–147. 
15. Spitzer RL, Kroenke K, Williams JB, The patient health questionnaire primary care study 
group: Validation and utility of a self-report version of the PRIME-MD: the PHQ 
primary care study. JAMA 1999, 282:1737–1744. 
16. Lowe B, Kroenke K, Herzog W, Grafe K: Measuring depression outcome with a brief 
self-report instrument: sensitivity to change of the PHQ-9. J Affect Dis 2003, 81:61–66. 
17. Roy T, Lloyd CE, Pouwer F, Holt RIG, Sartorius N: Screening Tools used for 
measuring depression among people with type 1 and type 2 diabetes: a systematic 
review. Diabet Med 2012, 29(2):164–175. 
18. Newnham EA, Hooke GR, Page AC: Monitoring treatment response and outcomes 
using the World Health Organization's wellbeing index in psychiatric care. J Affect 
Disord 2010, 122(1–2):133–138. 
19. Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AJ, Heine RJ, et 
al: Prevalence of comorbid depression is high in out-patients with type 1 or type 2 
diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med 
2010, 27(2):217–224. 
20. Bech P, Olsen LR, Kjoller M, Rasmussen NK: Measuring well-being rather than 
absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and 
the WHO-Five Well-being scale. Int J Methods Psychiatr. Res 2003, 12:85–91. 
21. Reddy P, Ford D, Dunbar JA: Improving the quality of diabetes care in general 
practice. Aust J Rural Health 2010, 18(5):187–193. 
22. Shim RS, Baltrus P, Ye J, Rust G: Prevalence, treatment, and control of depressive 
symptoms in the United States: results from the National Health and Nutrition 
Examination Survey (NHANES), 2005–2008. J Am Board Fam Med 2011, 24(1):33–38. 
23. Holt RIG, Phillips DIW, Jameson KA, Cooper C, Dennison EM, Peveler RC: The 
relationship between depression and diabetes mellitus: findings from the Hertfordshire 
Cohort study. Diabet Med 2009, 26:641–648. 
24. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV: 
Examining a bidirectional association between depressive symptoms and diabetes. 
JAMA 2008, 299(23):2751–2759. 
25. Engum A: The role of depression and anxiety in onset of diabetes in a large 
population-based study. J Psychosom Res 2007, 62(1):31–38. 
26. Lloyd CE CE, Dyer PH, Barnett AH: Prevalence of symptoms of depression and 
anxiety in a diabetes clinic population. Diabet Med 2000, 17(3):198–202. 
27. Richardson LK, Egede LE, Mueller M, Echols CL, Gebregziabher M: Longitudinal 
effects of depression on glycemic control in veterans with type 2 diabetes. Gen Hosp 
Psychiatry 2008, 30:509–514. 
28. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ: Association of 
depression and diabetes complications: a metaanalysis. Psychosom Med 2001, 63:619–
630. 
29. Dickerson F, Brown CH, Fang L, Goldberg RW, Kreyenbuhl J, Wohlheiter K, et al: 
Quality of life in individuals with serious mental illness and type 2 diabetes. 
Psychosomatics 2008, 49:109–114. 
30. Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE, et al: Prevalence of 
depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a 
systematic review and meta-analysis of the European Depression in Diabetes (EDID) 
research consortium. Diabetes Care 2011, 34(3):752–762. 
31. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al: Type 2 diabetes 
mellitus as a risk factor for the onset of depression: a systematic review and meta-
analysis. Diabetologia 2010, 53(12):2480–2486. 
32. Talbot F, Nouwen A: A review of the relationship between depression and diabetes in 
adults: is there a link? Diabetes Care 2000, 23:1556–1562. 
33. Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the 
lifespan: a meta-analysis. Diabetes Care 2008, 31(12):2383–2390. 
34. Simmons D, Gamble GD, Foote S, Cole DR, Coster G: The New Zealand diabetes 
passport study: a randomized controlled trial of the impact of a diabetes passport on 
risk factors for diabetes-related complications. Diabet Med 2004, 21:214–217. 
35. Phillips LS, Branch WT, Cook CB, et al: Clinical inertia. Ann Intern Med 2001, 
135:825–834. 
36. Rubin RR, Ciechanowski P, Egede LE, Lin EH, Lustman PJ: Recognizing and treating 
depression in patients with diabetes. Curr Diab Rep 2004, 4:119–125. 
37. Pouwer F, Snoek FJ, van der Ploeg HM, Adèr HJ, Heine RJ: Monitoring of 
psychological well-being in outpatients with diabetes: effects on mood, HbA(1c), and the 
patient's evaluation of the quality of diabetes care: a randomized controlled trial. 
Diabetes Care 2001, 24(11):1929–1935. 
38. Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH, Bazelmans E, Beekman AT, Heine RJ, et 
al: Limited effect of screening for depression with written feedback in outpatients with 
diabetes mellitus: a randomised controlled trial. Diabetologia 2011, 54(4):741–748. 
39. Pouwer F: Should we screen for emotional distress in type 2 diabetes mellitus? Nat 
Rev Endocrinol 2009, 5(12):665–671. 
40. Morgan MAJ, Dunbar J, Reddy P: Collaborative care. The role of practice nurses. Aust 
Fam Physician 2009, 38(11):925–926. 
A random sample of 417 recruited through three diabetic 
outpatient clinics in Dhaka and Sylhet 
BIRDEM Hospital 
Approached & assessed 
for eligibility (n=196) 
NHN Facility 
Approached & 
assessed for eligibility 
(n =98) 
BADAS Hospital, Sylhet 
Approached & assessed 
for eligibility (n= 189) 
Total approached & 
assessed for eligibility 
in 3 clinics 
(n = 483)
Excluded (n=66) 
Did not matched eligibility 
criteria (n=33) 
Refused to take part (n=5) 
Unable to take part – required in 
other clinical area for 
investigation (n=28) 
Consented & took 
part (n=163)  
Total participated 
(n=417) 
Consented & took 
part (n=168)  
Consented & took 
part (n=86)  
Evaluation proforma 
completed for both methods 
(n=417) 
WHO-5 completed  
(n=417) 
PHQ-9 completed 
(n=417) 
Excluded from 
analysis (n=0)   
Eligible for analysis 
(n=417)  
Analyzed 
(n=417)  Figure 1
